Bionime Corporation designs, manufactures, and sells medical instruments in China, Switzerland, the United States, Belarus, Algeria, the United Arab Emirates, Egypt, and internationally. The company manufactures and sells blood glucose meters and test strips to medical equipment companies, pharmacies, and hospitals, as well as offering blood glucose monitoring devices and systems under the RIGHTEST brand; a continuous glucose monitoring system under the iFree CGM brand; and medical blood glucose management systems. It is also involved in the provision of biotechnology services; drug testing; examination of pharmaceutical products; and the sale of precision instruments. The company also provides wholesale medical devices, biotechnology services, pharmaceutical testing, and wholesale of precision instruments. Bionime Corporation was incorporated in 2003 and is based in Taichung, Taiwan.
Frequently asked questions
What sector does Bionime Corp (4737) operate in?
Bionime Corp belongs to the Healthcare sector and operates in the Medical Instruments & Supplies industry.
What is Bionime Corp (4737) current stock price?
As of the latest data, Bionime Corp stock price is NT$59.90, with a previous close of NT$59.90.
What is Bionime Corp (4737) current market capitalization?
Bionime Corp market cap is approximately 4.63 billion.
What is Bionime Corp (4737) Earnings Per Share (EPS)?
The trailing EPS is -NT$4.10.
What is Bionime Corp (4737) EBITDA?
Bionime Corp EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -8.80 million.
Does Bionime Corp (4737) pay dividends?
No. Bionime Corp does not pay a dividend.
What is Bionime Corp (4737) beta (volatility) score?
Bionime Corp has a beta of -0.134, indicating lower volatility than the overall market.
